It is therefore possible that TRPM2 inhibition could provide the same effects in breast cancer cells that are refractive to chemotherapy, particularly those that evade apoptotic cell death, and thus survive after chemotherapy. The gene discussed is TRPM2; the disease is breast carcinoma.